Jacqueline S. Gardner

1.2k total citations
35 papers, 897 citations indexed

About

Jacqueline S. Gardner is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Jacqueline S. Gardner has authored 35 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 11 papers in Pediatrics, Perinatology and Child Health and 11 papers in Pharmacology. Recurrent topics in Jacqueline S. Gardner's work include Reproductive Health and Contraception (13 papers), Pharmaceutical industry and healthcare (10 papers) and Global Maternal and Child Health (7 papers). Jacqueline S. Gardner is often cited by papers focused on Reproductive Health and Contraception (13 papers), Pharmaceutical industry and healthcare (10 papers) and Global Maternal and Child Health (7 papers). Jacqueline S. Gardner collaborates with scholars based in United States, United Kingdom and Canada. Jacqueline S. Gardner's co-authors include David K. Blough, Leslie Miller, Andy Stergachis, Deborah Shatin, David J. Graham, Sean D. Sullivan, Stephanie T. Le, Janet R. Daling, Susan R. Heckbert and Kathleen E. Malone and has published in prestigious journals such as PLoS ONE, Cancer and Biochemical Journal.

In The Last Decade

Jacqueline S. Gardner

34 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqueline S. Gardner United States 18 438 366 141 106 99 35 897
Emmanuel Oga United States 18 421 1.0× 226 0.6× 216 1.5× 54 0.5× 84 0.8× 52 1.2k
Nancy Stark United States 12 191 0.4× 128 0.3× 100 0.7× 45 0.4× 79 0.8× 18 574
L T W de Jong-van den Berg Netherlands 13 187 0.4× 179 0.5× 63 0.4× 89 0.8× 107 1.1× 24 670
Yoon Jung Chang South Korea 20 306 0.7× 159 0.4× 188 1.3× 11 0.1× 79 0.8× 77 1.0k
John van den Anker United States 12 252 0.6× 402 1.1× 50 0.4× 70 0.7× 74 0.7× 51 850
Seanna Vine United States 15 314 0.7× 79 0.2× 99 0.7× 29 0.3× 71 0.7× 43 844
Anne Zajicek United States 16 273 0.6× 284 0.8× 51 0.4× 92 0.9× 44 0.4× 31 759
Mikael Hoffmann Sweden 15 161 0.4× 103 0.3× 111 0.8× 18 0.2× 76 0.8× 49 973
Cristina Aguilera Spain 10 94 0.2× 172 0.5× 26 0.2× 26 0.2× 79 0.8× 54 690
Jenny S. Guadamuz United States 16 179 0.4× 93 0.3× 109 0.8× 21 0.2× 36 0.4× 52 636

Countries citing papers authored by Jacqueline S. Gardner

Since Specialization
Citations

This map shows the geographic impact of Jacqueline S. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline S. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline S. Gardner more than expected).

Fields of papers citing papers by Jacqueline S. Gardner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline S. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline S. Gardner. The network helps show where Jacqueline S. Gardner may publish in the future.

Co-authorship network of co-authors of Jacqueline S. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline S. Gardner. A scholar is included among the top collaborators of Jacqueline S. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline S. Gardner. Jacqueline S. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Babigumira, Joseph B., Andy Stergachis, David L. Veenstra, et al.. (2012). Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda. PLoS ONE. 7(2). e30735–e30735. 26 indexed citations
2.
Cross, James T., David L. Veenstra, Jacqueline S. Gardner, & Louis P. Garrison. (2011). Can Modeling of Health Outcomes Facilitate Regulatory Decision Making?: The Benefit–Risk Tradeoff for Rosiglitazone in 1999 vs. 2007. Clinical Pharmacology & Therapeutics. 89(3). 429–436. 1 indexed citations
3.
Gardner, Jacqueline S., et al.. (2008). Pharmacist prescribing of hormonal contraceptives: Results of the Direct Access study. Journal of the American Pharmacists Association. 48(2). 212–226. 101 indexed citations
4.
Miller, Leslie, et al.. (2006). Agreement between women's and providers' assessment of hormonal contraceptive risk factors. Contraception. 73(5). 501–506. 62 indexed citations
5.
Miller, Leslie, et al.. (2005). Over-the-internet availability of hormonal contraceptives regardless of risk factors. Contraception. 73(4). 372–375. 21 indexed citations
6.
Boudreau, Denise M., Jacqueline S. Gardner, Kathleen E. Malone, et al.. (2004). The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women. Cancer. 100(11). 2308–2316. 99 indexed citations
7.
Shatin, Deborah, Jacqueline S. Gardner, Andy Stergachis, David K. Blough, & David J. Graham. (2004). Impact of mailed warning to prescribers on the co‐prescription of tramadol and antidepressants. Pharmacoepidemiology and Drug Safety. 14(3). 149–154. 36 indexed citations
8.
Stergachis, Andy, et al.. (2002). Improving Pediatric Asthma Outcomes In The Community Setting: Does Pharmaceutical Care Make A Difference?. Journal of the American Pharmaceutical Association (1996). 42(5). 743–752. 54 indexed citations
9.
Hazlet, Thomas K., et al.. (2002). Neuroleptic Drug Exposure and Incidence of Tardive Dyskinesia: A Records-based Case-Control Study. Journal of Managed Care Pharmacy. 8(4). 259–265. 4 indexed citations
10.
Chaiyakunapruk, Nathorn, et al.. (2001). Research: The Emergency Contraception Collaborative Prescribing Experience in Washington State. Journal of the American Pharmaceutical Association (1996). 41(1). 60–66. 31 indexed citations
11.
Sucato, Gina S., Jacqueline S. Gardner, & Thomas D. Koepsell. (2001). Adolescents' Use of Emergency Contraception Provided by Washington State Pharmacists. Journal of Pediatric and Adolescent Gynecology. 14(4). 163–169. 32 indexed citations
12.
Gardner, Jacqueline S., David K. Blough, Carol R. Drinkard, et al.. (2000). Tramadol and Seizures: A Surveillance Study in a Managed Care Population. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(12). 1423–1431. 119 indexed citations
13.
Gardner, Jacqueline S.. (2000). Establishing a Vaccine Administration Program in the Community Pharmacy. Journal of the American Pharmaceutical Association (1996). 40(1). 111–112. 3 indexed citations
14.
Gardner, Jacqueline S., et al.. (1999). Therapeutic interchange of conjugated and esterified estrogens in a managed care organization. American Journal of Health-System Pharmacy. 56(6). 537–542. 6 indexed citations
15.
Gardner, Jacqueline S., et al.. (1998). Acceptability of a Substitution of Estrogen Replacement Therapy to Women Enrolled in a Health Maintenance Organization. Journal of women's health. 7(8). 1027–1031. 8 indexed citations
16.
Gardner, Jacqueline S.. (1997). A Practical Guide to Establishing Vaccine Administration Services in Community Pharmacies. Journal of the American Pharmaceutical Association (1996). 37(6). 683–693. 23 indexed citations
17.
Voss, David, et al.. (1994). Diagnosis of Cortical Infarction in a Renal Transplant Using Ultrasonography. ˜The œNephron journals/Nephron journals. 68(3). 378–379. 2 indexed citations
18.
Facklam, D., et al.. (1990). An epidemiologic postmarketing surveillance study of prescription acne medications.. American Journal of Public Health. 80(1). 50–53. 4 indexed citations
19.
Facklam, D., et al.. (1988). Is post-marketing drug surveillance possible in the family practice setting? A collaborative study.. PubMed. 34. 819–22. 2 indexed citations
20.
Guess, Harry A., Wendy P. Stephenson, Susan T. Sacks, & Jacqueline S. Gardner. (1988). Beyond pharmacoepidemiology: The larger role of epidemiology in drug development. Journal of Clinical Epidemiology. 41(10). 995–996. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Oga Breakdown of academic impact, for papers by Nancy Stark Breakdown of academic impact, for papers by L T W de Jong-van den Berg Breakdown of academic impact, for papers by Yoon Jung Chang Breakdown of academic impact, for papers by John van den Anker Breakdown of academic impact, for papers by Seanna Vine Breakdown of academic impact, for papers by Anne Zajicek Breakdown of academic impact, for papers by Mikael Hoffmann Breakdown of academic impact, for papers by Cristina Aguilera Breakdown of academic impact, for papers by Jenny S. Guadamuz
Rankless by CCL
2026